Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy that can lead to severe weakness of the limbs, face, and respiratory muscles. Its pathophysiology involves autoantibodies that attack ...
Multiple vaccine candidates based on RNA and DNA technologies, inactivated viruses, and other approaches have been rapidly developed to combat the coronavirus disease 2019 (COVID-19) pandemic. Severe ...
Verywell Health on MSN
Herpes IgG Test: Purpose and What Results Mean
Medically reviewed by Laura Young, MD Key Takeaways A positive herpes IgG test result means you have or had a herpes infection.The herpes IgG test doesn't detect the virus itself; it detects ...
Researchers explore the link between immunoglobulins and blood profile in severe SARS-CoV-2 patients
A recent report posted to the Research Square* preprint server, whilst under consideration at the Clinical and Molecular Allergy journal, illustrated the association of immunoglobulins (Igs) with ...
Please provide your email address to receive an email when new articles are posted on . Belimumab after rituximab reduces serum IgG anti-double-stranded DNA antibody levels and the risk for severe ...
MedPage Today on MSN
FcRn Blockers Vie to Become First Approved Drug for Sjogren's Disease
FcRn blockers are approved for other indications: efgartigimod for adults with generalized myasthenia gravis and in ...
Many patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma do not undergo immunoglobulin G testing despite its potential to reduce likelihood of severe infections. Blood cancers increase ...
Antibody. Illustration of an immunoglobulin antibody molecule. This Y-shaped molecule has two arms that can bind to specific antigens, for instance viral or bacterial proteins. In doing this it marks ...
Study: MuSK-Specific Antibodies Do Not Explain Variation in Serum IgG4 Levels in People With MuSK MG
People with muscle-specific kinase myasthenia gravis appear to have more active antibody responses in general, the study found. People with muscle-specific kinase (MuSK) myasthenia gravis (MG) have ...
BHV-1300 reduced total IgG by up to 84% in a four-week Phase 1 study. The treatment was well-tolerated, with no serious adverse events reported. Get access to the leaderboards pointing to tomorrow’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results